• Jobs
  • Explore
  • Hire
LoginSign up

Beeline Medicines

Open roles 20

  • Beeline Medicines logo
    Associate Director, Pharmacovigilance Scientist

    Beeline Medicines

    • Cambridge, MA
    • Hybrid · Director / Executive
    • $181k–$235k
    Greenhouse
    Posted 18h 34m ago
  • Beeline Medicines logo
    Senior Accountant

    Beeline Medicines

    • Stamford, CT
    • Hybrid · Senior
    • $113k–$146k
    Greenhouse
    Posted 1d ago
  • Beeline Medicines logo
    Senior Director, Regulatory Affairs CMC

    Beeline Medicines

    • United States
    • Director / Executive
    • $242k–$314k
    Greenhouse
    Posted 5d ago
  • Beeline Medicines logo
    Associate Director, Medical Writing

    Beeline Medicines

    • United States
    • Director / Executive
    • $181k–$235k
    Greenhouse
    Posted 5d ago
  • Beeline Medicines logo
    Global Pharmacovigilance Medical Director

    Beeline Medicines

    • United States
    • Director / Executive
    • $266k–$344k
    Greenhouse
    Posted 19d ago
  • Beeline Medicines logo
    Senior Medical Affairs Operations Manager

    Beeline Medicines

    • Cambridge, MA
    • Hybrid · Senior
    • $165k–$215k
    Greenhouse
    Posted 21d ago
Show all roles

About

Beeline Medicines logo

Beeline Medicines

Let’s get to what matters. To life lived fully.

Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies to transform the lives of people living with autoimmune and inflammatory diseases. We are here to chart a new path for patients, rigorously pushing the science forward to deliver therapies that go straight to the drivers of immune dysfunction to define new treatment paradigms. Our portfolio is comprised of therapeutic candidates rooted in validated biology, powered by best-in-class molecular properties, and driven by an efficient clinical development strategy designed for differentiated, lasting impact for patients. Grounded in scientific rigor and driven by purpose, we get to what matters so that people living with immune-mediated diseases can live life fully.

Private companySeries AMega roundIn the newsBrand new
Founded2025
HQStamford, United States
Unlock human wisdom
ThesisTermsPrivacy
Size51–200 employees
IndustryBiotechnology Research
Funding
  • Series A · $426.3M · Jun 30, 2026
Investors
Bain CapitalCPP InvestmentsBristol-Myers Squibb
News
  • Beeline's afimetoran meets primary endpoint in Phase 2 lupus trial across all doses
  • Beeline Medicines Announces Presentation of Phase 2 Results of Afimetoran in Systemic Lupus Erythematosus at ACR Convergence 2026
  • Beeline Medicines Announces Presentation of Phase 2 Results of Afimetoran in Systemic Lupus Erythematosus at ACR Convergence 2026
  • Beeline Medicines to Present Results from the Phase 2 Trial of Afimetoran in Systemic Lupus Erythematosus as a Late-Breaking Oral Presentation at ACR Convergence 2026

Claim beelinemedicines.com

Work at beelinemedicines.com? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.